Health
Peru suspends trials with China’s Covid 19 vaccine due to a “serious adverse event” – MercoPress
Peru suspended trials for China’s Sinopharm Covid-19 vaccine due to a “serious adverse event” that occurred with one of the volunteers for the study, the Peruvian…
Monday, December14th2020 – 08:59 UTC
Sinopharm Group, which is conducting its trials in Peru with some 12,000 volunteers, was about to complete the first stage of the trials in the next few days
Peru suspended trials for China’s Sinopharm Covid-19 vaccine due to a “serious adverse event” that occurred with one of the volunteers for the study, the Peruvian government said in a statement on Saturday.
The health ministry said the event is “under investigation to determine if it is related to the vaccine…
-
Business21 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Noosa News24 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants